Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Artículo en Inglés | WPRIM | ID: wpr-8811

RESUMEN

Neuropeptide Y (NPY) receptors are present in cardiac membranes. However, its physiological roles in the heart are not clear. The aim of this study was to define the direct effects of pancreatic polypeptide (PP) on atrial dynamics and atrial natriuretic peptide (ANP) release in perfused beating atria. Pancreatic polypeptides, a NPY Y4 receptor agonist, decreased atrial contractility but was not dose-dependent. The ANP release was stimulated by PP in a dose-dependent manner. GR 23118, a NPY Y4 receptor agonist, also increased the ANP release and the potency was greater than PP. In contrast, peptide YY (3-36) (PYY), an NPY Y2 receptor agonist, suppressed the release of ANP with positive inotropy. NPY, an agonist for Y1, 2, 5 receptor, did not cause any significant changes. The pretreatment of NPY (18-36), an antagonist for NPY Y3 receptor, markedly attenuated the stimulation of ANP release by PP but did not affect the suppression of ANP release by PYY. BIIE0246, an antagonist for NPY Y2 receptor, attenuated the suppression of ANP release by PYY. The responsiveness of atrial contractility to PP or PYY was not affected by either of the antagonists. These results suggest that NPY Y4 and Y2 receptor differently regulate the release of atrial ANP.


Asunto(s)
Animales , Ratas , Arginina/análogos & derivados , Factor Natriurético Atrial/metabolismo , Benzazepinas/farmacología , Regulación de la Expresión Génica , Polipéptido Pancreático/farmacología , Péptido YY/farmacología , Ratas Sprague-Dawley , Receptores de Neuropéptido Y/agonistas
2.
Yonsei Medical Journal ; : 99-105, 1980.
Artículo en Inglés | WPRIM | ID: wpr-60600

RESUMEN

Pancreatic polypeptie (PP) is released from the pancreas in response to vagal stimulation. Amongst other effects, PP has been reported to inhibit pancreatic exocrine function. Apart from any potential physiological role, such inhibition could have important consequences for in vitro studies of pancreatic function employing acetylcholine as a stimulus. We have therefore tested the effect of bovine PP on two in vitro pancreatic preparations: the incubated, uncinate pancreas of young rats and the perfused cat pancreas. In the former, PP (10(-10)-10(-8)M) had little or no effect on enzyme discharge or45Ca efflux under basal conditions or during stimulation with caerulein, CCK-PZ or acetylcholine. In the perfused cat pancreas, similar concentrations of PP were also without effect on fluid secretion evoked by secretin infusion, or enzyme discharge evoked by CCK-PZ injection or infusion. We conclude that bovine PP has no direct effects on the cellular mechanisms responsible for pancreatic electrolyte secretion or enzyme discharge in the species studied.


Asunto(s)
Gatos , Ratas , Acetilcolina/farmacología , Amilasas/metabolismo , Animales , Ceruletida/farmacología , Calcio/metabolismo , Colecistoquinina/farmacología , Electrólitos/metabolismo , Técnicas In Vitro , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Polipéptido Pancreático/farmacología , Perfusión , Secretina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA